156 related articles for article (PubMed ID: 28121942)
1. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.
Ye M; Huang T; Li J; Zhou C; Yang P; Ni C; Chen S
Medicine (Baltimore); 2017 Jan; 96(4):e5956. PubMed ID: 28121942
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
Yang J; Niu H; Huang Y; Yang K
PLoS One; 2016; 11(5):e0149185. PubMed ID: 27153114
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
4. Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.
Duan BS; Xie LF; Wang Y
Cancer Genomics Proteomics; 2017; 14(4):277-284. PubMed ID: 28647701
[TBL] [Abstract][Full Text] [Related]
5. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis.
Chen F; Huang T; Ren Y; Wei J; Lou Z; Wang X; Fan X; Chen Y; Weng G; Yao X
BMC Urol; 2016 Aug; 16(1):52. PubMed ID: 27578166
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline.
Zhu C; Feng X; Ye G; Huang T
Medicine (Baltimore); 2017 Apr; 96(16):e6650. PubMed ID: 28422868
[TBL] [Abstract][Full Text] [Related]
8. Role of CDH1 promoter methylation in colorectal carcinogenesis: a meta-analysis.
Li YX; Lu Y; Li CY; Yuan P; Lin SS
DNA Cell Biol; 2014 Jul; 33(7):455-62. PubMed ID: 24684676
[TBL] [Abstract][Full Text] [Related]
9. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the diagnostic role of CDH13 promoter methylation in lung cancer.
Zhong YH; Peng H; Cheng HZ; Wang P
Asian Pac J Cancer Prev; 2015; 16(3):1139-43. PubMed ID: 25735345
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
[TBL] [Abstract][Full Text] [Related]
12. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.
Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Br J Cancer; 2004 Mar; 90(5):1030-3. PubMed ID: 14997203
[TBL] [Abstract][Full Text] [Related]
13. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer.
Wang L; Lin YL; Li B; Wang YZ; Li WP; Ma JG
J Int Med Res; 2014 Oct; 42(5):1085-92. PubMed ID: 25015764
[TBL] [Abstract][Full Text] [Related]
15. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis.
Li YW; Kong FM; Zhou JP; Dong M
Tumour Biol; 2014 Jul; 35(7):6783-90. PubMed ID: 24729088
[TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation of the SFRP1 gene may contribute to colorectal carcinogenesis: a meta-analysis.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
Tumour Biol; 2014 Sep; 35(9):9201-10. PubMed ID: 24929326
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.
Lin YL; Xie PG; Ma JG
Med Sci Monit; 2014 Sep; 20():1572-7. PubMed ID: 25196672
[TBL] [Abstract][Full Text] [Related]
19. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
[TBL] [Abstract][Full Text] [Related]
20. Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa.
Roman-Gomez J; Castillejo JA; Jimenez A; Cervantes F; Boque C; Hermosin L; Leon A; Grañena A; Colomer D; Heiniger A; Torres A
J Clin Oncol; 2003 Apr; 21(8):1472-9. PubMed ID: 12697869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
